Adma Biologics reported $4.05B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Adma Biologics USD 4.08B 267M Sep/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Dynavax Technologies USD 1.19B 421M Jun/2025
Takeda JPY 7.04T 19.15B Jun/2025